Concepedia

Geoffrey R. Weiss

GR

142

Publications

14.6K

Citations

62

H-Index

1978

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

City Of Hope National Medical Center

SWOG Cancer Research Network

Cancer Research And Biostatistics

Brooke Army Medical Center

Geoffrey R. Weiss is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1978–2020

142

Publications

142

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Karen Kelly, John Crowley, Paul A. Bunn et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

David F. McDermott, Meredith M. Regan, Joseph I. Clark et al. · Journal of Clinical Oncology · 2004 · 814 citations

A Southwest Oncology Group study

Terry R. Jenkins, Catherine M. Tangen, John S. Macdonald et al. · 1993 · 775 citations

, , +16

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

Stephanie Green, Geoffrey R. Weiss · Investigational New Drugs · 1992 · 613 citations

, , +8

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.

Agnieszka Woźniak, John J. Crowley, S P Balcerzak et al. · Journal of Clinical Oncology · 1998 · 566 citations

Rows per page

1–5 of 142